Brief: Talenom Lowers Its Guidance For 2025

Talenom

15/12/2025 08:14

Dec 15 (Reuters) - Talenom Oyj TNOM.HE:

LOWERS ITS GUIDANCE FOR 2025

ESTIMATES THAT 2025 NET SALES WILL BE AROUND EUR 129-131 MILLION

ESTIMATES 2025 EBITDA AROUND EUR 33-35 MILLION INCLUDING COSTS ARISING FROM STRATEGIC REVIEW, SEPARATION AND LISTING

PREVIOUS GUIDANCE: ESTIMATES THAT 2025 NET SALES WILL BE AROUND EUR 130–140 MILLION, EBITDA AROUND EUR 36–42 MILLION

COSTS FOR 2025 FROM STRATEGIC REVIEW, SEPARATION, LISTING OF NEW INDEPENDENT CO TO BE ESTABLISHED AFTER SEPARATION ARE ESTIMATED TO TOTAL AROUND EUR 1.2 MILLION

HAS CARRIED OUT FEWER ACQUISITIONS THAN PLANNED DURING 2025, WHICH HAS DECREASED NET SALES AND EBITDA GENERATION

WEAKENING OF DEMAND CAUSED BY PROLONGED ECONOMIC DOWNTURN, PARTICULARLY IN FINLAND, HAS AFFECTED NET SALES ACCUMULATION MORE THAN ESTIMATED, ESPECIALLY IN LAST QUARTER OF THE YEAR

WEAKER-THAN-EXPECTED GROWTH IN THE LAST QUARTER ACROSS GROUP HAS NEGATIVELY IMPACTED BOTH CO'S NET SALES AND EBITDA

Further company coverage: TNOM.HE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))